Yukari Kobayashi

2.7k citations
68 papers · 2.1k indexed · h-index 18

Yukari Kobayashi

64 papers receiving 2.0k citations

Peers

Yukari Kobayashi
Comparison fields: 5 of 106
  • Oncology 913
  • Clinical Biochemistry 154
  • Radiology, Nuclear Medicine and Imaging 447
  • Biochemistry 138
  • Immunology 368
Replace Michael Clemens with:
Michael Clemens Germany
Shuiying Hu United States
Navjotsingh Pabla United States
Margarita de la Llera-Moya United States
J. Greg Slatter United States
N. B. Myant United Kingdom
David Carlile United Kingdom
Kari M. Morrissey United States
Ashish Saxena United States
S. Calandra Italy
Yukari Kobayashi relative to Michael Clemens Germany Michael Clemens's profile →
Citations per field
00.5×2.6×
Michael Clemens · 1×
Citations per year

Countries citing papers authored by Yukari Kobayashi

Since Specialization
Citations

This map shows the geographic impact of Yukari Kobayashi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yukari Kobayashi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yukari Kobayashi more than expected).

Fields of papers citing papers by Yukari Kobayashi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yukari Kobayashi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yukari Kobayashi. The network helps show where Yukari Kobayashi may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Yukari Kobayashi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Yukari Kobayashi Line = papers co-authored together Yukari Kobayashi links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20252
2 20243
3 20238
4 20233
5 20231
6 20227
7 202214
8 202113
9 202111
10 20216
11 20209
12 20181
13 201621
14 20141
15 20131
16 20120
17 20113
18 20072
19 20076
20 200015

About Yukari Kobayashi

Yukari Kobayashi is a scholar working on Oncology, Immunology and Gastroenterology, having authored 68 papers that have together received 2.1k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (23 papers), Immune Cell Function and Interaction (10 papers), Immunotherapy and Immune Responses (7 papers), Drug Transport and Resistance Mechanisms (6 papers), Ovarian cancer diagnosis and treatment (6 papers), Amino Acid Enzymes and Metabolism (5 papers), Gastric Cancer Management and Outcomes (5 papers) and Immune cells in cancer (5 papers). The work is most often cited by research in Oncology (913 citations), Clinical Biochemistry (154 citations) and Radiology, Nuclear Medicine and Imaging (447 citations). Yukari Kobayashi has collaborated with scholars based in Japan, United States and China. Frequent co-authors include Hitoshi Endou, Seok Ho, Takashi Sekine, Tomoyuki Goya, Yoshikatsu Kanai, Junichi Fukushima, Rinpei Niwa, Kazuyasu Nakamura, Kenya Shitara and Atsushi Enomoto. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Journal of the American College of Cardiology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026